Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis

Area of Science:

• Dermatology
• Immunology

Background:

• Pustular psoriasis (PP) and acute generalized exanthematous pustulosis (AGEP) present with overlapping clinical and histopathological features, leading to diagnostic challenges.
• Both conditions are characterized by sterile pustules, primarily composed of neutrophils, making differentiation difficult based solely on pustule morphology.

Purpose of the Study:

• To elucidate the key differentiating factors between pustular psoriasis and acute generalized exanthematous pustulosis.
• To highlight the distinct treatment strategies required for each condition.

Main Methods:

• Comparative analysis of clinical presentations, including patient history and physical examination findings.
• Histopathological examination to identify characteristic features of each condition.

Main Results:

• Clinical indicators favoring PP include a history of psoriasis and the presence of scaling plaques.
• Histological findings such as eosinophilic spongiosis, vacuolar interface dermatitis, and dermal eosinophilia suggest AGEP.
• PP treatment involves topical steroids, oral retinoids, and systemic immunosuppressants, with emerging therapies targeting IL-36, IL-23, IL-1, and PDE-4.
• AGEP management critically relies on the removal of the causative agent.

Conclusions:

• Accurate differentiation between PP and AGEP is essential due to their differing clinical courses and treatment requirements.
• Recognizing specific clinical and histological clues aids in distinguishing these two pustular dermatoses.
• Tailored treatment strategies, ranging from topical therapies and systemic agents for PP to prompt withdrawal of offending drugs for AGEP, are paramount for effective patient outcomes.